Bioactivity:

Rilapladib is a selective Lipoprotein-Associated Phospholipase A2 inhibitor (IC50: 230 pM). Rilapladib is also a Platelet Activating Factor Receptor antagonist.

CAS nr:

412950-08-4

Purity:

98%

Molecular Weight:

735,81

SMILES:

O=C(N(C1CCN(CCOC)CC1)CC2=CC=C(C3=CC=C(C(F)(F)F)C=C3)C=C2)CN4C(SCC5=CC=CC(F)=C5F)=CC(C6=C4C=CC=C6)=O

Formula:

C40H38F5N3O3S

Pathway:

Metabolism

Target:

Phospholipase